Vendor, Washington, MO, part of R-Biopharm Inc.
R-Biopharm, Inc.
UEI E9NXLK97A3Q3, CAGE 3NBU7
1 award and -$61 obligated between October 29, 2025 and October 29, 2025, 0% under full and open competition, against 3.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 | -$61 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSF223201300564PPurchase Order, October 29, 2025, Competed Under SAP, 3 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Ridascreen Fast Peanut KitsNAICS 325413, PSC 6550 | -$61 |
- Places of performance
- New York
- Product and service codes
- 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
- Transactions
- 1 across 1 awards